considerably reduced when the animals were infected intragastrically, suggesting that some quantitative differences existed between the sensitizing antigenic contents of the two test organisms.
The expression of acquired resistance to salmonellosis depends upon the combined humoral and cellular responses of the infected host (7) . Specific serum immunoglobulins play a primary role during the early clearance phase of the infection (5) , but once the organisms become established in an intracellular environment within the liver and spleen, their subsequent elimination depends upon a cellmediated type of immune response (19) . The inability of dead Salmonella vaccines to induce this type of cellular response has been cited as one reason for their inferior mouse protective value, at least in comparison with the antimicrobial type of resistance exhibited by convalescent animals (6) . It is believed that the immunogenicity of living attenuated vaccines is related to their ability to survive in vivo, rather than on the closeness of the phylogenetic relationship between the vaccine and challenge strains (8) . This belief stems largely from the finding that some strains of Mycobacterium intracellulare, Mycobacterium kansasii, and BCG are unable to survive when injected into normal mice and such strains also fail to immunize the host against a subsequent tuberculous challenge, despite the fact that other closely related mycobacteria may be highly protective (9) . Living S. pullorum vaccines are neither allergenic nor immunogenic for normal mice (13) .
Both living and killed S. pullorum suspensions induce the production of specific opsonins which may influence the early behavior of a virulent S. enteritidis challenge, but there is no indication that such a vaccine induces an antibacterial immunity in the host, despite the presence of the somatic antigens 0-9 and 0-12 in both organisms (3, 15) . Recent studies indicated that the protective value of a heat-inactivated S. enteritidis vaccine can be greatly promoted by incorporation of the organisms into Freund complete adjuvant (11) . The present investigation extends these findings to heatkilled S. pullorum vaccines which are also able to induce effective levels of acquired resistance against both systemic and oral S. enteritidis challenges provided that the organisms are first incorporated into Freund complete adjuvant. (15) .
RESULTS
Vaccination with living salmonellae. Mice vaccinated intravenously with attenuated salmonellae have repeatedly been shown to develop a solid resistance to superinfection (15, 17, 25) . However, intravenous inoculation of the highly susceptible C57BI strain of mice with even small numbers of S. enteritidis 5694 results in the death of a substantial proportion of the "vaccinated" mice. On the other hand, subcutaneous inoculation results in a slower evolution of the systemic Salmonella infection (5) (Fig. 1) . By the second day, the infection had reached the liver and spleen where the organisms multiplied steadily until about the seventh day of the infection. Thereafter, an emerging resistance limited further growth and the systemic infection slowly subsided. Superinfection of the vaccinated mice with 10 to 100 LD50 of S. enteritidis 5694 SMR (given intravenously on day 14) was followed by an immediate and rapid decline in the numbers of viable streptomycin-resistant bacteria in the liver and spleen, indicating the presence of high levels of acquired anti-Salmonella resistance (Fig. 1 ). Another group of the vaccinated mice were infected intragastrically with approximately 100 LD50 of S. enteritidis SMRt, and these animals also failed to develop a systemic drugresistant S. enteritidis infection (Fig. 2) .
Past attempts to immunize mice with S. pullorum by using the intravenous route have been uniformly unsuccessful; the organisms were rapidly eliminated from the tissues and the mice remained fully susceptible to a later S. enteritidis challenge (13, 15 Fig. 1 that, although substantial numbers of S. pullorum reached the , popliteal lymph node within hours of infection, Z 6 the organisms were rapidly eliminated from all 0 =G the tissues tested. By day 7, no viable S. =4 \ t pullorum could be detected in vivo: a second f 7/ inoculum of S. pullorum was eliminated some-<=2-//6DA what more rapidly from the footpad and regional lymph nodes, but the vaccinated mice < were still fully susceptible to intravenous (Fig. ,, (Fig. 3) . Once estab-days previously with live S. enteritidis (bottom) or S. lished in vivo, the orally induced infections pullorum (top). Abbreviations: G, gut; MN, mesenprogressed at much the same rate in vaccinated teric lymph nodes; Sp, spleen; Lr, liver. and control animals. The growth pattem seen in the vaccinated mice was consistent with the mortality data in Fig. 3 (expressed as the number of dead mice out of 10 challenged animals).
Effect of adjuvant on the immunogenicity of killed S. pullorum. Nelson and Mildenhall (21) reported that mice develop delayed hypersensitivity when immunized with antigens suspended in Freund incomplete adjuvant. But in the present study, mice which had been immunized with one or two doses of 200 Ag of heat-killed S. pullorum (S. enteritidis gave essentially the same results) suspended in incomplete Freund adjuvant showed very little evidence of protection (Fig. 4) . On the other hand, two doses of heat-killed organisms in complete Freund adjuvant gave good protection against the oral challenge as evidenced by reduced bacterial growth and an improved host survival (Fig. 4) .
At a dose of 200 ug given twice in Freund complete adjuvant, S. pullorum and S. enteritidis both gave complete protection against the lethal effects of oral and intravenous challenges and comparable degrees of resistance as measured by bacterial growth in various tissues (Fig. 5) . The peak liver and spleen populations seen in the orally challenged mice were consistently 10-to 100-fold lower than in the corresponding controls; none of the immunized mice died, whereas 2 out of 10 controls were dead by day 10 (Fig. 5) . When the dose of antigen was reduced to 40 Mg, enhanced resistance to an intravenous S. enteritidis challenge was seen with both vaccines. All protective value was lost when the dose was reduced further to 8 Mg of heat-killed S. enteritidis or S. (Fig. 6) . A difference in immunogenicity did emerge, however, when the oral route was used to challenge mice immunized with varying doses of heat-killed S. enteritidis and S. pullorum in Freund complete adjuvant ( Table 1 ). The S. enteritidis populations in the livers and spleens of mice vaccinated with 200 ug of either organism were significantly lower when tested 8 days after challenge in comparison with the corresponding figures for the unvaccinated controls. Mice vaccinated with Freund adjuvant alone showed only a half-log decrease, which was not significant at the 5% level. Counts obtained in mice given two 40-Ag doses of S. pullorum were not significantly reduced, indicating that this organism was somewhat less immunogenic than S. enteritidis at least when the oral route of challenge was employed.
DISCUSSION
The level of acquired resistance developed by an immunized animal appears to vary when the routes of vaccination and challenge are changed (7, 9) . It is known, for instance, that the host response to intravenously injected BCG is quan-S. enteritidis challenge I.V.
Fround's complete adjuvant alone titatively superior to that achieved with other routes of vaccination (1, 2). The intravenously injected inoculum engages much more of the lymphoreticular system, and the resulting immune response is apt to be larger and earlier in onset as a consequence. Eventually, intradermal infection spreads to draining lymph nodes and may become systemic, but the tempo of the infection and the magnitude of the immune response will generally be lower. But the development of maximum levels of acquired resistance in response to the immunizing infection may not be the prime consideration in selecting the route of immunization. When immunizing C57Bl x dba F1 hybrid mice, for example, the extreme virulence of S. enteritidis for this mouse strain (intravenous LD,0 of five organisms) must be borne in mind. Even small infectious doses of a partially attenuated strain can result in the death of a substantial proportion of the "vaccinated" animals. This difficulty is circumvented by the use of the intradermal route of inoculation. The resulting systemic infection then develops slowly enough for the mice to induce adequate levels of cellular resistance before the bacterial population can reach toxic proportions. In practical terms, the resistance developed in this way appears to be similar to that observed earlier for intravenously immunized animals (13) .
Despite the presence of common somatic antigens, live S. pullorum is unable to induce detectable levels of acquired resistance against either an intravenous or intragastric challenge with S. enteritidis (15) . One obvious explanation for this lack of cross-protection would be the absence of one or more critical sensitizing or "protective" antigens from the cell walls of S. pullorum (18) . However, the demonstrated ability of heat-killed S. pullorum vaccines to effectively protect mice against both intravenous and intragastric challenges with S. enteritidis (provided that the vaccinating organisms are first suspended in Freund complete adjuvant) clearly eliminates this possibility. If both Salmonella species contain adequate amounts of sensitizing antigen(s), then they should both be equally efficient at inducing an effective antibacterial type of resistance. Comparative protection studies carried out using decreasing amounts of dead S. enteritidis or S. pullorum (suspended in Freund complete adjuvant) indicate quantitative differences in the amount of sensitizing antigen(s) in the two strains; this difference was never sufficient to explain the lack of immunogenicity in living S. pullorum vaccines, however.
The precise nature of the sensitizing antigens of the Salmonella species is presently unknown, although there is some evidence that the antigens may be nucleoprotein (22) or glycoprotein (13) in nature. Since living S. pullorum is unable to induce either a specific delayed hypersensitivity or acquired antimicrobial resistance (despite the known presence of the necessary sensitizing antigens in the whole organism; reference 12), it would seem only reasonable to assume that this is due to an inability of S. pullorum to survive in vivo. Earlier studies showed that both S. enteritidis and S. gallinarum were highly immunogenic for CD-1 mice and multiplied extensively in vivo, producing numerous focal lesions throughout the liver and spleen (15, 20) . The organisms within the lesions presumably release antigens into the surrounding tissues where they induce those cellular changes associated with the development of delayed hypersensitivity (19) . However, no such situation occurs in the case of S. pullorum. Since the organism is unable to establish a stable infection within the normal mouse tissues, there will be no infectious foci from which the sensitizing antigen(s) can be slowly released into the surrounding granuloma (20) . Presumably the amount of sensitizing antigen released from a massive dose of rapidly inactivated cells will be too small or will be taken up by cells unable to induce an effective acquired resistance. It is possible that the organism must release specific antigenic products which are only present in the actively multiplying cell. The nature of these critical antigenic components is unknown, but they probably bear no relationship to the smooth somatic antigens of the bacterial cell wall (13) . The absence of a direct role for the smooth somatic antigens in the induction of cellular hypersensitivity may explain why living (but not heat-killed) vaccines prepared from some rough salmonellae can protect mice against a subsequent challenge with a fully smooth virulent organism (16, 24) . Presumably the rough salmonellae have sensitizing antigens able to induce the necessary cellular response on the part of the host; to do this the organism must be able to survive in vivo, and the resulting cellular activation of the host defenses is then able to nonspecifically protect the host against the antigenically unrelated virulent challenge. S. pullorum is known to be partially rough, and such strains are more sensitive to the bactericidal action of normal and immune sera than is the case for the fully smooth organisms (3) . Despite this increased sensitivity, many rough strains of Salmonella can persist in vivo for several days or even weeks (16, 18, 24) , and such organisms are able to induce good cross-protection in mice. Unfortunately there is still relatively little quantitative data available regarding the behavior of rough strains of salmonellae within the reticuloendothelial organs of normal mice; the relevance of such detailed information, in terms of the development of acquired resistance to both parenteral and oral challenges, is quite obvious, however. Clearly, more work needs to be done in this area, particularly with respect to the nature of the sensitizing antigen(s) present in these organisms.
